|
biomedicina slovenica |
pr=Bohanec-Grabar : 17
-
Bohanec-Grabar Petra; Leandro-Garcia Luis J; Inglada-Perez Lucia; Logar Dušan; Rodriguez-Antona Cristina; Dolžan Vita
Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
2012 ►
-
Bohanec-Grabar Petra; Rojko Sabina; Logar Dušan; Dolžan Vita
Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
2010 ►
-
Bohanec-Grabar Petra; Rozman Blaž; Logar Dušan; Dolžan Vita
Pharmacogenetics - a step further towards personalized DMARD treatment of rheumatoid arthritis
2009 ►
-
Bohanec-Grabar Petra; Logar Dušan; Tomšič Matija; Rozman Blaž; Dolžan Vita
Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients
2009 ►
-
Bohanec-Grabar P; Logar D; Tomšič M; Rozman B; Dolžan V
Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis
2009 ►
-
Bohanec-Grabar Petra; Grabnar Iztok; Rozman Blaž; Logar Dušan; Tomšič Matija; Šuput Daša; Trdan Tina; Peterlin-Mašič Lucija; Mrhar Aleš; Dolžan Vita
Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis
2009 ►
-
Bohanec-Grabar P; Rozman B; Logar D; Praprotnik S; Dolžan V
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arhritis
2009 ►
-
Bohanec-Grabar Petra; Grabnar Iztok; Mrhar Aleš; Rozman Blaž; Logar Dušan; Tomšič Matija; Praprotnik Sonja; Dolžan Vita
Genetic polymorphisms of CYP1A2 and CYP2C19 influence leflunomide treatment in rheumatoid arthritis patients
2008 ►
-
Bohanec-Grabar Petra; Logar Dušan; Lestan B; Dolžan Vita
Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
2008 ►
-
Bohanec-Grabar Petra; Logar Dušan; Tomšič Matija; Rozman Blaž; Dolžan Vita
Genetic polymorphisms controlling oxidative stress influence the activity of rheumatoid arthritis
2007 ►
-
Bohanec-Grabar Petra; Grabnar Iztok; Mrhar Aleš; Rozman Blaž; Logar Dušan; Tomšič Matija; Praprotnik Sonja; Dolžan Vita
Genetic polymorphisms of CYP1A2 and CYP2C19 influence leflunomide treatment in rheumatoid arthritis patients
2008 ►
-
Bohanec-Grabar Petra; Rozman Blaž; Tomšič Matija; Šuput Daša; Logar Dušan; Dolžan Vita
Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
2008 ►
-
Bohanec-Grabar P; Logar D; Lestan B; Dolžan V
Genetic polymorphisms in folate metabolic pathway increase the risk for adverse effects during methotrexate treatment in rheumatoid arthritis
2006 ►
-
Bohanec-Grabar Petra; Logar Dušan; Lestan Boris; Dolžan Vita
Genetic polymorphisms in folate metabolic pathway increase the risk for adverse effects during methotrexate treatment in rheumatic arthritis
2007 ►
-
Bohanec-Grabar Petra; Rozman Blaž; Logar Dušan; Tomšič Matija; Dolžan Vita
Genetic polymorphism of CYP1A2 and CYP2C19 and the outcome of leflunomide tratment in rheumatoid arthritis patients
2007 ►
-
Bohanec-Grabar Petra; Dolžan Vita; Rodriguez-Antona Cristina
Role of pharmacogenetics for the improvement of cancer tratment
[Vloga farmakogenetike pri učinkovitejšem zdravljenju raka]
2007 ►
-
Bohanec-Grabar Petra; Logar Dušan; Lestan Boris; Dolžan Vita
Genetic polymorphisms in folate metabolic pathway influence the risk for developing adverse effects during methotrexate treatment in rheumatoid arthritis
2007 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics